Peter Altman
Fortuna: 277 387 $ al 31/05/2026
Fortuna: 277 387 $ al 31/05/2026
Peter Alan Altman was the founder of CareDx, Inc., founded in 1998, where the title held was Director from 2003 to 2014.
Dr. Altman was the founder of Lumen Therapeutics, founded in 2004, where the title held was Chief Executive Officer from 2004 to 2005.
Dr. Altman is also the founder of Sinus Rhythm Technologies, Inc...
Dr. Altman is currently President, Chief Executive Officer & Director at BioCardia, Inc. since 2002.
Dr. Altman is Chief Executive Officer at BioCardia Lifesciences, Inc. Dr. Altman is Director at Oncocyclist Biotech since 2018.
Former jobs include President, Chief Executive Officer & Director at BioCardia, Inc. and Principal at Ventritex, Inc. Education includes a doctorate from the University of California, Berkeley, a doctorate from The University of California, San Francisco, and undergraduate and graduate degrees from Fu Foundation School of Engineering & Applied Science.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOCARDIA, INC. 2,62 % | 09/06/2026 | 298.266 ( 2,62 % ) | 277 387 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOCARDIA, INC. | Director Ejecutivo | 01/01/2002 |
Oncocyclist Biotech | Director/Miembro de la Junta | 01/01/2018 |
BioCardia Lifesciences, Inc.
BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| CAREDX, INC. | Fundador | 01/01/2014 |
Lumen Therapeutics
Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director Ejecutivo | 01/01/2005 |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Director Ejecutivo | - |
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Corporate Officer/Principal | - |
Sinus Rhythm Technologies, Inc.
Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Health Technology |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinus Rhythm Technologies, Inc.
Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
Lumen Therapeutics
Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Fu Foundation School of Engineering & Applied Science
Fu Foundation School of Engineering & Applied Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCardia, Inc.
BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
BioCardia Lifesciences, Inc.
BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Oncocyclist Biotech |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.